Add this topic to your myFT Digest for news straight to your inbox
Two former board members tell Congress they do not bear personal responsibility for addiction epidemic
Investigators must bring to book the highest profile perpetrators
Punitive actions do not just exact narrow justice — they serve as a deterrent against future misdeeds
Members of billionaire Sackler family to pay $225m in related civil settlement
Some states have targeted family members in opioid lawsuits after company bankruptcy
Opiod maker owned by Sackler family has yet to reach deal with all attorneys-general
Purdue Pharma strikes a preliminary deal with US states over opioid crisis claims
New York, Pennsylvania and Washington among those to rebuff settlement
Companies feel pressure to temper profit-seeking with social duty
Opioid maker Purdue Pharma offers to settle thousands of lawsuits for up to $12bn
Plaintiffs must decide whether to accept the deal by Friday as company eyes bankruptcy
State tries unusual legal move over alleged ‘massive cash transfers’ to Sackler family members
Reckitt Benckiser’s $1.4bn settlement is the largest penalty so far linked to the epidemic
Donald Trump says that Huawei could be included in a trade deal with Beijing
OxyContin maker has been accused of playing a key role in fuelling the US opioid crisis
Donations are increasingly caricatured as self-protective ruses for the wealthy
Germany’s telecoms regulator says Huawei can stay in the 5G network race
Opioid maker sought drug group that treats abuse of its own painkillers
Purdue Pharma owners file motion to dismiss lawsuit from Massachusetts attorney-general
State files ‘nation’s most extensive lawsuit’ against a raft of drugmakers and distributors
Deal with Oklahoma by Purdue Pharma and Sackler family owners could be first of many
Move by major funder comes as arts organisations face pressure to stop accepting its gifts
US opioid crisis campaigner plans to target unnamed arts organisation in London
It is time for a broad review of philanthropic donations and investments
Decision follows US legal action over opioid links to companies owned by family members
International Edition